Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH

Name: Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH
License: Public Domain

United Therapeutics

ClinicalTrials.gov · Datasets · License: Public Domain

pulmonary arterial hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325199
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.